Study group |
NAM supplement |
Treatment |
(abbreviation) |
(mg/kg of diet) |
(number of rats) |
Control (C) |
20 |
Un-restrained (10) |
Restrained (10) | ||
Pair-fed (PF) |
20 |
Un-restrained (10) |
Restrained (10) | ||
NAM deficiency (ND) |
Not Available |
Un-restrained (10) |
Restrained (10) | ||
Low-dose
NAM supplement (LNS) |
40 |
Un-restrained (10) |
Restrained (10) | ||
High-dose
NAM supplement (HNS) |
500 |
Un-restrained (10) |
Restrained (10) |
Study group/period |
Week 1 |
Week 2 |
Week 5 | |||
|
|
| ||||
Un-restrained |
50.8 ± 13.8 |
37.8 ± 13.4 |
45.3 ± 12.2 | |||
Restrained |
53.4 ± 15.1 |
31.9 ± 11.9 |
31.5 ± 14.6 | |||
|
|
| ||||
Un-restrained |
59.2 ± 22.2 |
9.6 ± 4.2 |
9.9 ± 3.6 | |||
Restrained |
51.5 ± 15.2 |
8.2 ± 7.4 |
10.3 ± 2.1 | |||
NAM supplement1 |
|
|
| |||
Un-restrained |
55.1 ± 13.8 |
78.9 ± 46.9 |
135.0 ± 39.6 | |||
Restrained |
57.2 ± 24.1 |
84.6 ± 48.3 |
97.7 ± 48.2 | |||
P values |
NMN |
NMN ´ nutriture |
NMN ´ stress |
NMN´ nutriture ´ stress | ||
|
<0.001 |
<0.001 |
0.519 |
0.013 | ||
Study group |
Latency |
Crossing |
Rearing |
Modification |
|
(s) |
(time) |
(time) |
(time) |
|
|
|
| |
Un-restrained |
3.7 ± 2.3 |
45.8 ± 21.9 |
16.0 ± 12.6 |
2.6 ± 2.0 |
Restrained |
7.3 ± 6.1 |
47.8 ± 18.3 |
17.8 ± 6.6 |
4.8 ± 2.8 |
|
|
|
| |
Un-restrained |
12.9 ± 13.9 |
46.4 ± 9.6 |
16.0 ± 5.5 |
0.8 ± 1.0 |
Restrained |
19.9 ± 19.9 |
37.0 ± 19.4 |
14.0 ± 8.0 |
1.5 ± 1.7 |
|
|
|
| |
Un-restrained |
8.6 ± 9.9 |
35.9 ± 10.3 |
13.8 ± 5.4 |
5.7 ± 6.5 |
Restrained |
19.6 ± 23.3 |
28.1 ± 19.9 |
8.8± 4.8 |
4.2 ± 3.0 |
NAM supplement1 |
|
|
|
|
Un-restrained |
6.7 ± 5.0 |
44.3 ± 22.0 |
15.5 ± 6.8 |
3.5 ± 2.8 |
Restrained |
8.2 ± 5.2 |
50.2 ± 14.9 |
15.7 ± 5.2 |
2.8 ± 2.5 |
NAM supplement2 |
|
|
|
|
Un-restrained |
15.9 ± 10.7 |
21.3 ± 17.7 |
9.0 ± 7.4 |
2.3 ± 2.3 |
Restrained |
7.2 ± 5.1 |
38.8 ± 20.1 |
15.6 ± 6.6 |
2.8 ± 1.9 |
P values |
|
|
|
|
Nutriture |
0.028 |
0.005 |
0.089 |
0.004 |
Stress |
0.150 |
0.650 |
0.830 |
0.667 |
Nutriture´ stress |
0.017 |
0.124 |
0.135 |
0.131 |
Study group |
Un-restrained |
Restrained | |||
Control |
7.59 ± 1.48 |
8.88 ± 1.03 | |||
Pair-feed |
7.61 ± 1.60 |
6.65 ± 1.58 | |||
NAM deficiency |
5.22 ± 1.10 |
6.61 ± 1.79 | |||
NAM supplement1 |
8.42 ± 2.05 |
7.89 ± 2.42 | |||
NAM supplement2 |
6.61 ± 1.00 |
7.51 ± 1.33 | |||
All |
7.09 ± 1.83 |
7.50 ± 1.82 | |||
P values |
Nutriture |
Stress |
Nutriture´ stress | ||
|
<0.001 |
0.201 |
0.069 | ||
|
NO |
NOS |
Study group |
(mmol/L) |
(unit/mg protein) |
|
| |
Un-restrained |
31.31 ± 10.30 |
0.27 ± 0.10 |
Restrained |
40.41± 26.23 |
0.23 ± 0.07 |
|
| |
Un-restrained |
46.16± 25.23 |
0.23 ± 0.06 |
Restrained |
66.70± 45.68 |
0.27 ± 0.11 |
|
| |
Un-restrained |
43.09± 13.16 |
0.26 ± 0.08 |
Restrained |
42.18± 19.67 |
0.31 ± 0.06 |
NAM supplement1 |
|
|
Un-restrained |
49.78± 31.40 |
0.53 ± 0.18 |
Restrained |
53.72± 42.26 |
0.48 ± 0.11 |
NAM supplement2 |
|
|
Un-restrained |
21.03± 9.67 |
0.59 ± 0.29 |
Restrained |
52.86± 37.43 |
0.48 ± 0.15 |
P values |
|
|
Nutriture |
0.086 |
<0.001 |
Stress |
0.055 |
0.475 |
Nutriture´ stress |
0.243 |
0.332 |
|
Insulin |
Glucose |
Study group |
(mIu/ml) |
(mmol/L) |
|
| |
Un-restrained |
15.82 ± 2.54 |
8.40 ± 1.95 |
Restrained |
16.44± 3.55 |
8.26 ± 1.94 |
|
| |
Un-restrained |
24.07± 6.32 |
7.97 ± 1.68 |
Restrained |
20.16± 6.25 |
7.58 ± 2.82 |
|
| |
Un-restrained |
9.59± 4.97 |
7.36 ± 1.87 |
Restrained |
14.18± 4.86 |
8.15± 1.15 |
NAM supplement1 |
|
|
Un-restrained |
16.83± 3.60 |
8.64 ± 1.24 |
Restrained |
19.84± 2.21 |
9.52 ± 1.38 |
NAM supplement2 |
|
|
Un-restrained |
18.82± 2.70 |
9.18 ± 1.14 |
Restrained |
19.20± 2.72 |
8.94 ± 1.21 |
P values |
|
|
Nutriture |
<0.001 |
0.031 |
Stress |
0.390 |
0.609 |
Nutriture´ stress |
0.022 |
0.664 |
|
Total
n=68 |
Intervention
n=35 |
Control
n=33 |
Age (years) |
21.9 ± 2.8 |
22.2 ± 3.1 |
21.5 ± 2.4 |
Education (≥ high school, %) |
78 |
80 |
76 |
BMI (kg/m2) |
23.3 ± 2.3 |
23.6 ± 2.5 |
22.9 ± 2.2 |
SBP (mmHg) |
103 ± 15 |
105 ± 10 |
101 ± 19 |
DBP (mmHg) |
67 ± 9 |
67 ± 11 |
67 ± 8 |
HR (min) |
72 ± 8 |
71 ± 8 |
73 ± 9 |
Cortisol (ng/ml) |
347.3 ± 87.5 |
360.1 ± 102.6 |
333.7 ± 66.8 |
NOS (unit/ml) |
30.8 ± 3.4 |
31.2 ± 3.3 |
30.3 ± 3.5 |
NO (µmol/L) |
38.7 ± 36.5 |
35.3 ± 38.7 |
42.7 ± 33.9 |
|
Intervention
n=30 |
Control
n=28 |
Significance
(P value) |
Appetite increase (%) |
32 |
18 |
0.205 |
Sleep prolonging (%) |
32 |
11 |
0.046 |
Sleep quality improvement (%) |
36 |
25 |
0.382 |
Mood improvement (%) |
32 |
32 |
0.992 |
Nausea (%) |
3 |
7 |
0.494 |
Headache (%) |
19 |
11 |
0.357 |
Fidget (%) |
16 |
14 |
0.844 |
|
Intervention
n=30 |
Control
n=28 |
Significance
(P value) | ||
SCL-90 positivea (%) |
30 |
25 |
0.670 | ||
Sight reaction | |||||
Time (s) |
3408.1 ± 978.3 |
3676.1 ± 776.9 |
0.255 | ||
Error frequency |
10.6 ± 5.7 |
10.4 ± 9.3 |
0.904 | ||
Digit memory reactionb |
17.7 ± 3.9 |
16.5 ± 3.5 |
0.207 | ||
|
Intervention
n=30 |
Control
n=28 |
Significance
(P value) |
SBP (mmHg) |
109 ± 11 |
108 ± 12 |
0.725 |
DBP (mmHg) |
65 ± 8 |
65 ± 8 |
0.976 |
HR (min) |
71 ± 6 |
73 ± 9 |
0.203 |
Cortisol (ng/ml) |
291.6 ± 97.1 |
278.5 ± 79.2 |
0.585 |
NOS (unit/ml) |
35.6 ± 4.3 |
33.9 ± 5.5 |
0.195 |
较高浓度NAM可使细胞存活率显著下降,而较低浓度则对细胞存活率无明显影响(图7)。
Figure 7 Cell survival rates with different levels of NAM treatment